🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This prospective randomized pilot trial will evaluate a multiple interventi...
Status
Active Not Recruiting
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2019-07-23
Trial ID
NCT03654105
This phase Ib trial will investigate the effect of N-803 in combination wit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07217496
This phase II trial compares therapeutic plasma exchange followed by enfort...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-08-01
Trial ID
NCT07087860
Rationale: Individuals with a cancer predisposition due to a mutation in th...
Status
Completed
Location
Institute Curie
Start Date
2018-12-13
Trial ID
NCT04164134
Treatments Being Tested
This phase II trial tests how well enfortumab vedotin (EV) and pembrolizuma...
Status
Recruiting
Location
Grady Health System
Start Date
2023-09-26
Trial ID
NCT05756569
Clinical implication of eventual blood biomarkers for stroke diagnosis and ...
Status
Unknown
Location
Neurocenter of Southern Switzerland, Ospedale Civico
Start Date
2022-11-18
Trial ID
NCT06319742
Treatments Being Tested
The objective of this prospective multicenter study is to evaluate whether ...
Status
Not Yet Recruiting
Location
CHU Besançon - Service Dermatologie
Start Date
2026-03-01
Trial ID
NCT07376512
The purpose of this study is to determine whether biomarkers could be found...
Status
Unknown
Location
VU University Medical Center
Start Date
2014-03
Trial ID
NCT02109913
Treatments Being Tested
This study is a retrospective case-control study. In this study, through un...
Status
Completed
Location
Weiping Li
Start Date
2017-05-23
Trial ID
NCT05601310
Treatments Being Tested
This pilot feasibility clinical trial is evaluating a novel treatment strat...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-08-20
Trial ID
NCT07579195
Treatments Being Tested